Deep vein thrombosis in the calf happens when blood clots form in the deep veins below the knee, typically in the posterior tibial, peroneal, or anterior tibial veins. Three conditions drive clot formation in these veins: sluggish blood flow, damage to the vein wall, and blood that clots too easily. Most calf DVTs result from a combination of at least two of these factors, and understanding which ones apply to you helps explain why the clot formed and how likely it is to happen again.
The Three Conditions Behind Every Clot
Every DVT traces back to a framework doctors have used for over a century, built on three overlapping triggers: stasis (slow-moving blood), vessel wall injury, and hypercoagulability (blood that’s prone to clotting). Rarely does just one of these cause a clot on its own. Usually two or three converge at the same time.
Stasis is especially relevant in the calf because blood in the lower legs already moves slowly, fighting gravity on its return to the heart. The deep veins in your calf have small pockets near their valves where blood naturally pools. During periods of immobility, blood in these valve pockets becomes oxygen-depleted within hours. That low-oxygen environment triggers the vein lining to release proteins that kickstart the clotting process while simultaneously suppressing the body’s built-in clot-dissolving system. The result: a clot forms right at the valve cusp, exactly where blood sits the longest.
Vessel wall injury can be obvious, like trauma from a fracture, surgery, or a catheter. It can also be subtle, caused by inflammation or pressure from a tumor. When the inner lining of a vein is damaged, it exposes collagen and releases compounds that attract platelets and accelerate clotting. The vein also constricts at the injury site, further slowing blood flow.
Hypercoagulability means the blood itself is more prone to clotting than normal. This can happen because of genetic mutations, cancer, inflammation, dehydration, or certain medications. When clotting factors circulate in higher-than-normal concentrations, even minor stasis or slight vein wall irritation can tip the balance toward a clot.
Surgery and Immobility
Surgery is one of the strongest triggers for calf DVT because it hits all three conditions at once: you’re immobile under anesthesia (stasis), tissue is being cut and manipulated near veins (vessel injury), and your body ramps up clotting activity as part of the healing response (hypercoagulability).
Without preventive measures, DVT rates after major orthopedic procedures are striking. Hip replacement carries a 42% to 57% rate of detectable clots, knee replacement 41% to 85%, and hip fracture surgery 46% to 60%. Many of these clots form in the calf veins first. General abdominal and pelvic surgeries carry lower but still significant risk, with DVT rates of 15% to 30%. Major gynecologic surgery falls in a similar range. These numbers reflect cases found on imaging, not just symptomatic ones, which is why hospitals now routinely use blood thinners and compression devices around surgery.
Immobility without surgery matters too. Long hospital stays, bed rest from illness, leg casts or braces, and extended travel all reduce the pumping action of the calf muscles that normally pushes blood upward through the deep veins. Being bedridden for more than three days is considered a significant risk factor on its own.
Hormones and Medications
Combined oral contraceptives are one of the most common medication-related causes of DVT in younger women. Estrogen increases the liver’s production of several clotting factors, shifting the blood toward a more clot-prone state. Women using oral contraceptives have roughly a 6-fold increased risk of venous thrombosis compared to non-users. The risk varies by formulation: pills containing levonorgestrel carry about a 5.4-fold increase, while those containing desogestrel raise the risk roughly 10-fold.
Postmenopausal hormone therapy also increases clotting risk, though typically less dramatically than oral contraceptives. Pregnancy raises DVT risk through a combination of higher estrogen levels, increased blood volume, and compression of pelvic veins by the growing uterus, all of which slow return flow from the legs.
Genetic Clotting Disorders
Some people inherit gene mutations that make their blood clot more readily. The most common is Factor V Leiden, a mutation found in about 3.5% of the general population but present in roughly 14.5% of people who develop venous thrombosis. Carrying this mutation increases the odds of DVT about fourfold. Another inherited condition, a prothrombin gene mutation, similarly raises clotting risk.
These mutations often cause no problems on their own for years. The clot typically occurs when a genetic tendency combines with a situational trigger, like starting birth control pills, having surgery, or sitting through a long flight. This is why some people develop DVT from activities that millions of others do without issue. If you develop a clot without an obvious cause, or at a young age, testing for inherited clotting disorders can help explain why and guide decisions about long-term prevention.
Cancer, Obesity, and Other Medical Conditions
Cancer is a potent driver of DVT. Tumors release substances that activate the clotting cascade, and some cancers directly compress or invade veins. Chemotherapy and cancer surgery add further risk. An unprovoked DVT, one with no clear trigger, sometimes turns out to be the first sign of an undiagnosed cancer.
Obesity significantly increases DVT risk. Compared to people with a BMI under 25, those who are overweight (BMI 25 to 30) have a 40% higher risk of venous thrombosis, and those with obesity (BMI 30 or above) face an 86% higher risk. Excess abdominal weight compresses the veins in the pelvis and thighs, slowing venous return from the calves. Obesity also promotes a chronic low-grade inflammatory state that tips the blood toward easier clotting.
Other medical conditions that raise risk include heart failure (which reduces the force driving blood back to the heart), inflammatory bowel disease, nephrotic syndrome, and any condition causing prolonged immobility such as stroke or spinal cord injury. A prior DVT is itself a risk factor: the damaged vein and scarred valves create conditions that favor new clots.
How Calf DVT Feels
Calf DVT typically causes a dull ache in the lower leg that worsens with walking and improves with rest. You may notice mild swelling confined to the calf, along with focal tenderness when pressing on the area. Some people have no symptoms at all, and the clot is discovered incidentally during imaging for something else. Compared to clots in the thigh or pelvis, calf DVTs tend to produce milder, more localized symptoms. About 80% of DVTs that cause noticeable leg symptoms involve the larger proximal veins above the knee rather than the calf veins alone.
Doctors assess DVT likelihood using a scoring system that adds up risk factors: active cancer, recent surgery or immobilization, leg swelling, tenderness along the deep veins, a calf more than 3 cm larger than the other side, pitting edema, prior DVT history, and visible non-varicose surface veins each contribute a point. If another diagnosis seems equally or more likely, two points are subtracted. A score of 3 or higher puts you in the high-probability category, while a score below 2 makes DVT unlikely. This scoring helps determine whether you need an ultrasound, a blood test, or both.
What Happens if a Calf DVT Goes Untreated
Calf DVTs are sometimes called “distal” DVTs because they sit below the knee, and they carry lower risk than clots in the thigh or pelvis. Still, they aren’t harmless. Without treatment, roughly one quarter to one third of symptomatic calf DVTs extend upward into the larger proximal veins, where the risk of a clot breaking loose and traveling to the lungs (pulmonary embolism) becomes much more serious. In one study, 29% of patients with isolated calf DVT who received only short-term blood thinners had their clot recur or extend within three months.
Because of this propagation risk, doctors either treat calf DVT with anticoagulation or monitor it closely with repeat ultrasounds over the following two weeks. The decision often depends on how many risk factors you have, whether the clot involves one vein or several, and whether you have symptoms. A small, incidentally found clot in someone whose temporary risk factor has resolved (like a healed fracture) may warrant monitoring alone, while a larger or symptomatic clot, or one in a person with ongoing risk factors like cancer, typically gets treated.